Eli Lilly is dropping CVS Health's drug benefit plan for its employees after CVS stopped covering its weight-loss drug in ...

The company's shares (LLY) climbed 2.3% Tuesday to end at $988.62 a share, after closing at a record high of $966.64 on Monday. The rally has pushed Lilly's market capitalization up to $934.6 billion, ...

Lower prices for 15 drugs, including Ozempic and Wegovy, are expected to be announced by the end of the month. The price ...

What Happened: According to Reuters, Pfizer Inc (NYSE: PFE) won the bidding war against Novo Nordisk and will purchase ...

Novo Nordisk has cut prices of its weight-loss drug Wegovy by up to 37% in India. This move intensifies competition with Eli ...

By Rishika Sadam BENGALURU (Reuters) -Danish drugmaker Novo Nordisk said on Tuesday it had cut the price of its weight-loss ...

Novo Nordisk cuts Wegovy prices in India by up to 33% to boost access and counter Mounjaro’s growing market lead.

Danish drugmaker Novo Nordisk has cut the price of its weight-loss drug Wegovy by up to 33% in India, a key battleground for ...

David Ricks' remarks followed a recent White House event where Trump announced his administration had reached a deal to lower ...

Danish drugmaker Novo Nordisk on Tuesday cut the price of its blockbuster weight-loss drug, Wegovy, by up to 33% in India, ...

As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...